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A b s t r a c t
Introduction: Over the last 10 years, there has been an increasing number of
patients with pacemaker (PM) and cardioverter-defibrillator (ICD). This study is
a retrospective analysis of indications for endocardial pacemaker and ICD lead
extractions between 2003 and 2009 based on the experience of three Polish
Referral Lead Extraction Centers. 
Material and methods: Since 2003, the authors have consecutively retrospec-
tively collected all cases and entered the information in the database. All patients
which had indication for lead extraction according to Heart Rhythm Society
Guidelines were included to final analyze. Between 2003 and 2005, the data were
analyzed together. Since 2006, data have been collected and analyzed annually.
Results: In each year, a significant increase in lead extraction was observed. The
main indications for LE were infections in 52.4% of patients. Nonfunctioning
lead extraction constituted the second group of indications for LE in 29.7% of
patients. During the registry period, the percentage of class I indications de-
creased from 80% in 2006 to only 47% in 2009. On the other hand, increasingly
more leads were removed because of class 2, especially class 2b. In 2009, 40%
of leads were extracted due to class 2b.
Conclusions: Polish Registry of Endocardial Lead Extraction 2003-2009, shows
an increasing frequency of lead extraction. The main indication for LE is infec-
tion: systemic and pocket. An increase in class 2, especially 2b, LE indication in
every center during the study period was found.
Key words: lead extraction indication, abandoned lead extraction, nonfunctional
lead extraction.
Introduction
Over the last ten years, there has been an increasing number of patients
with pacemaker (PM) and cardioverter-defibrillator (ICD) implantation.
Additionally, there are now lead extraction consensus experts for pro-
longing a patient’s life expectancy, many nonfunctional leads, indications
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for upgrading systems, and increasingly more com-
plications related and not related to leads [1]. 
In one of the largest European single-center stu-
dies, the most common indication for lead extrac-
tion (LE) was local and systemic infection [2]. It was
also the most frequent reason for lead extraction,
an indication seen in other published studies [3-5].
This is a class 1 indication according to the current
Heart Rhythm Society (HRS) consensus. Functional
and nonfunctional retained leads that can cause
life-threatening arrhythmia were a very rare indi-
cation for lead removal. On the other hand, other class
1 indications for lead extraction, venous thrombosis
or venous stenosis were not reported in these stud-
ies. Class 2 indication was very seldom utilized as
an indication for lead extraction. However, none of
the authors have analyzed class 2 indications over
the study period, which is now becoming increas-
ingly more frequent.
This study is a retrospective analysis of indica-
tions for endocardial pacemaker and ICD lead ex-
traction between 2003 and 2009 based on the
experience of three Polish referral lead extraction
centers (which handle more than 95% of all lead
extractions in Poland).
Material and methods 
Endocardial Lead Extraction is retrospective
study. Every one patient with indication for lead
extraction according to HRS were included to the
final analyses. There was no exclusion criteria.
Patients informed consent was signed with
patient’s agreement for lead extraction. There was
no ethic committee because of retrospective analy-
ses of this registry. Since 2003, the authors have
consecutively collected details case by case and
entered them in the database. At the beginning,
i.e., between 2003 and 2005, data were analyzed
for the 3-year period. Since 2006, data have been
collected and analyzed annually. All indications for
lead extraction from 2003 to 2009 were analyzed
according to the current Heart Rhythm Society Doc-
ument: Transvenous Lead Extraction: Heart Rhythm
Society Expert Consensus on Facilities, Training,
Indications, and Patient Management published in
May 2009 [1].
There was no statistical analyses in this study.
The data were presented as values of number of
the patient classified according to HRS lead extrac-
tion class. 
Results
Between 2003 and 2009, there were two main
lead extraction (LE) centers – Centers A and B. Since
then, the third one, Center C, has started to perform
LE procedures. 
At present, there are three major lead extraction
centers in Poland: one high volume center (Center A)
that handled 209 patients with lead extraction pro-
cedures in 2009 compared to 42 patients and 46 pa-
tients in the other two (Centers B and C). During the
study, 426 patients (i.e., 67%) had leads extracted in
Center A compared to 153 and 46 in Centers B and C. 
From 2006 to 2009, a marked increase in the num-
ber of patients with lead extraction (doubling every
year) was observed in Center A. A similar number was
noted in Centers B and C in 2009.
Figure 1 shows the number of patients with LE pro-
cedures in Centers A, B, and C in Poland from 2003
to 2009.
Lead extraction procedure according to the HRS
Expert Consensus [1] was defined as the removal
of a lead that has been implanted for more than one
year or regardless of the duration of the implant
requiring the assistance of specialized equipment
that is not included as part of the typical implant
package and/or removal of a lead from a route other
than via the implant vein. ICD leads may require
specialized extraction equipment even when the
implantation duration is less than 1 year. 
Manual, gentle probation traction was used as
the first approach for the not-so-old implanted leads
only if their mobility in the venous course was con-
firmed. If this method failed, leads were extracted
using dedicated tools such as a standard or locking
stylet, dilator sheaths, and modern, more sophisti-
cated systems (Evolution Perfecta, Cook Inc). To dis-
connect the actively fixed lead from the endocar-
dium, the fixation element was screwed out or the
total lead body was rotated under direct fluoroscopy.
These maneuvers were followed by extraction of the
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Figure 1. Total number of patients with lead extrac-
tion procedures in three centers A, B, and C from
2003 to 2009 
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ficient only for a small percentage of leads, because
other connective tissue and scar tissue surrounding
the lead in the atrial or venous course compelled ex-
tractors to use additional tools.
The majority (> 90%) of the leads were usually
removed via the same transvenous access by which
they were inserted; these were termed the implant
vein. During most (> 90%) lead extractions, diffe-
rent dedicated sheaths were utilized; they included
polypropylene (rarely Teflon), telescopic Byrd dila-
tors with different diameters (Cook) that served to
disrupt fibrotic attachments and metal sheaths for
the venous region – entry only. Sometimes, telesco-
ping sheaths or any extraction sheath were used as
a single sheath or were paired with a second sheath.
The use of two sheaths has advantages such as the
flexibility of the inner sheath and the stiffness of the
outer sheath to prevent kinking and to improve 
the effectiveness of advancement over the lead
without overstressing the lead. If dilator sheaths
were not effective, a decision to use the Evolution
Perfecta system (Cook) was made. However, this
method was used in less than 4% of patients. No
laser system was used for LE procedures registered
in the database. For leads without an accessible end-
ing in previous methods, venous entry was used
(dropped-in leads with proximal ending in vein), and
for leads accidentally broken during the extraction
procedure alternative approaches (jugular, femoral)
and other tools (e.g., Femoral Working Station – Cook,
lasso catheters, Dotter basket catheters or different
snares, and pigtail catheters) were used.
In the three main centers, cardiologists were the
primary operator (100% of procedures). In Centers A
and B, LE in the electrophysiology (EP) cath lab was
performed with a cardiothoracic surgeon on stand-
by, and in Center C, lead extraction took place in the
cardiothoracic operating room. All LE procedures
were performed with total intravenous anesthesia.
From January 2003 to December 2009, 625 pa-
tients underwent lead extraction procedures. Mean
patient age was 59.6 ±20 years (range: 19-86 years);
386 were male and 239 female. 
The main indication for LE was infection in 52.4%
of patients as evidenced by lead-dependent infec-
tive endocarditis: sepsis in 14.4% and pocket infec-
tion as evidenced by pocket abscess, device ero-
sion, and skin adherence in 38%.
Nonfunctional lead extraction, which was per-
formed during PM replacement, system revision or
upgrading (if contraindications were absent) com-
prised the second group of indications for LE in
29.7% of patients. In this group, the most frequent
reason for LE was lead failure in 16.7%. Other major
reasons for lead removal were ipsilateral venous
occlusion preventing access to the venous circula-
tion for the placement of an additional lead, when
there is no contraindication for using the contrala-
teral side (5% of patients), and a potentially dan-
gerous lead (risk of threat to the patients if left in
place) in 3.6% of patients. When a functional lead
was not used, it was extracted less frequently (i.e.,
RV pacing lead after upgrade to ICD), in 3%.
Indications for lead extraction according to classes
of the Heart Rhythm Expert Consensus are shown
in Figure 2.
During the Registry period, the percentage of
patients with class 1 indications decreased from
80% in 2006 to only 47% in 2009. On the other hand,
more leads were removed in classes 2a, 2b, and
even in 3. In 2009, 40% of patients had LE accord-
ing to class 2b (compared to 15% in 2006). It is
important to note that the percentage of patients
with class 2b indications was very similar to class I
in 2009 (47% in class 1 and 40% in class 2b). During
the study, 33% had LE which is in the current class
2b of the HRS Expert Consensus. 
Class 1: HRS Expert Consensus 
Indications for class 1 lead extraction in the Polish
Registry from 2003 to 2009 are shown in Table I.
For the last 6 years, pocket infection has been the
main indication in class 1 for lead removal; however,
there has been a decrease in the percentage of pa-
tients with this complication with indications for LE
(65% in 2006 and 27% in 2009). Although the num-
ber of patients with systemic and pocket infections
has been increasing every year, the percentage of
patients with LE was stable in systemic infection
and even decreased in pocket infection.
Class 2: HRS Expert Consensus
During the last 5 years, an increase in the number
of patients with lead extraction according to class 2
was observed. In 2009, half of the patients with lead
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Figure 2. Percentage of patients with lead extraction
procedures according to classes of the current Heart
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removal were in class 2 recommendation in Center A
(Figure 2). A similar very high percentage of class 2
recommendation in 2009 in Centers B and C was no-
ted. Figure 3 shows the number of patients with
lead extraction procedures according to class 2 indi-
cations during the Registry period in all centers.
Class 2 indications in Polish pacemaker 
and ICD endocardial lead extraction registry
Some years ago, the authors tried to introduce
more detailed indications for lead extraction to the
computerized database. Common practice showed
that in a lot of patients the lead was extracted due
to several reasons simultaneously. The authors tried
to select the most important criterion, but finally
the obtained results can indicate a tendency only.
The most important subgroup of reasons why the
decision about LE was undertaken included mal-
function of a previously functional lead (broken con-
ductor, lead isolation or connector) in 49.4% of
patients, too many leads in patients with a long life
expectancy but not a HRS criterion (functional and
nonfunctional leads) in 7.2%, too many leads in
patients who fulfilled the HRS criterion (functional
and nonfunctional leads) in 2.5%, change of pacing
mode, upgrading (functional and sometimes non-
functional lead) in 8.9%, nonfunctional PM lead
(high pacing threshold, undersensing, dislodgement,
extracardiac pacing, atrial lead, and permanent AF)
in 19.8%, nonfunctional ICD lead (damaged, high
pacing threshold, undersensing, dislodgement) in
patients with a long life prognosis in 5.5%, children
and young patients with strained nonfunctional lead
or other lead that should be abandoned in 6.7%.
Class 2 in 2009
The authors stress that among class 2 indications
for lead extraction, class 2b constitutes the majority.
The percentage of patients with lead removal in
class 2b ranged from 32% in Center C to 42% in Cen-
ter A. Class 2b showed a much more frequent indi-
cation compared to class 2a, independent of the
centers. The percentages of patients with lead ex-
traction in 2009 in classes 2a and 2b in centers A,
B, and C were as follows: Center A – 11% and 40%;
Center B – 5% and 36%, Center C – 8% and 32%.
The most common class 2b indication for lead
extraction was lead failure in all centers, although
Center B accounted for 80% of 2b class indications.
In Centers A, B and C, nonfunctional leads were the
most frequent reason for extraction. None of the
leads were extracted (functional and nonfunctional)
because a specific imaging technique was required
(e.g., MRI).
A summary of indications in class 2b in 2009 is
shown in Table II.
Use of the opposite chest side and abandon-
ment of leads in the previously used chest side is
not popular in Poland. Recently, the authors prefers
Variables Year Total
2003–2005 2006 2007 2008 2009
2003–2009
Systemic infections 6 4 15 27 37 89
Pocket infections 33 26 45 60 79 243
Ipsilateral venous occlusion preventing access to the venous 0 0 0 3 3 6
circulation for required placement of an additional lead when 
there is a contraindication for using the contralateral side
Superior vena cava stenosis or occlusion with limiting symptoms 0 0 0 0 2 2
Possibility of immediate threat to the patients if left in place 2 1 1 5 13 22
Life-threatening arrhythmias secondary to retained leads 0 0 1 0 1 2
Interference with the operation of implanted cardiac devices 0 0 0 1 2 3
Interference with the treatment of a malignancy 0 1 0 0 1 2
(radiation/reconstructive surgery)
Total number of patients with leads extracted in class I 41 32 62 96 138 369
of HRS Expert Consensus in Polish Registry 2003–2009
Table I. Number of patients with lead removal in class I in the Polish Registry, 2003–2009
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Figure 3. Number of patients with lead extraction in
three centers according to the current class II HRS
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not to use ipsilateral side during lead implantation.
The au thors preferred to save the collateral side for
other medi cal utilities (AV fistula for hemodialysis,
permanent catheter, or implantation of a new sys-
tem in case of infection).
Class 2b, i.e., “nonfunctional leads”, is a very he-
terogeneous group. It must be stressed that the fol-
lowing groups of patients with very different “lead
complications” belong to this group: patients with
lead damage (a lot of symptomatically damaged
Sprint Fidelis comprise this subgroup), lead dislod-
gement, elevated or high pacing threshold, per-
manent AF with sinus rhythm failed with atrial lead,
intramural penetration/transmural perforation, two
ICD leads, two or more endocardial leads, and a gro-
wing child with strained nonfunctional lead. 
Hence, it can be seen that each of the afore-
mentioned groups of patients with nonfunctional
leads can cause a new, huge clinical challenge.
However, in some patients, there is “only” a 2b indi-
cation in a high percentage of leads extracted in
clinical practice, which shows that sometimes the
guidelines – even current ones – might be followed
in clinical practice. 
It is also important to note that the high per-
centage of class 2b LE, which ranges from 32% to
40% (Table II), is independent of the center. This
also proves to be a real clinical problem.
Class 3: HRS Expert Consensus
In class 3, the main indication for lead extraction
was the anomalous placement of leads through
structures other than normal venous and cardiac
structures. There were 10 (1.6%) such indications in
the registry – 6 in Center A, 1 in B, and 3 in C. The
procedures performed were ex-atrial/ventricular wall
perforating leads and extractions of leads errone-
ously permanently implanted via the atrial septum
(atrial septal defect (ASD), patent foramen ovale
(PFO)) into the left ventricle cavity. The procedures
were performed under special safety precautions
including cardiosurgery standby and carotid artery
protection. 
There were two main classes of lead extraction
indications in 2009 in all centers: classes 1 and 2b.
Class 1 showed a decrease in the percentage of pro-
cedures during the last 6 years. On the other hand,
a huge increase in class 2b indications was noted.
The main reason for lead removal in this class was
nonfunctional lead removal at the time of an indi-
cated cardiovascular implantable electronic device
(CIED) procedure, if contraindications are absent. The
most frequent reason for lead extraction in 128 pa-
tients in class 2b in 2009 was lead fracture in 71 pa-
tients (55%). The number of and expected LE/mil-
lion/year are shown in Table III.
Discussion
In the Polish Registry of 619 patients from 2003
to 2009, lead extractions were performed in three
main centers – two of them started procedures over
6 years ago, the last one in 2009. Since the begin-
ning of the study, an increase in the numbers of
patients with lead extractions has been noted. The
main indication since 2003 has been infection; how-
ever, a decrease in the percentage of such proce-
dures during the registry period was observed. On
the other hand, an increasing number of class 2b
indications was noted during the registry period,
2003-2009. The main reason for LE in class IIB was
lead damage.
Most frequently, the leads were extracted due
to different forms of damage; this group contains
patients with a damaged ICD lead (Sprint-Fidelis
predominantly), damaged PM leads in relatively
young patients with long-term life expectancy, and
Number of patients with class IIB indication Center A Center B Center C
Functional lead
Lead removal may be considered in patients with an abandoned functional lead that poses 5 0 8
a risk of interference with the operation of the active CIED system
Lead removal may be considered in patients with leads that are functional but 8 0 0
not being used. (i.e., RV pacing lead after upgrade to ICD)
Lead removal may be considered in patients who require specific imaging techniques 0 0 0
(e.g., MRI) that cannot be imaged due to the presence of the CIED system for which there 
is no other available imaging alternative for the diagnosis
Nonfunctional leads
Lead removal may be considered at the time of an indicated CIED procedure, in patients 71 15 21
with nonfunctional leads, if contraindications are absent Lead Lead Lead
fracture fracture fracture
– 47 (56%) – 12 (80%) – 12 (57%)
Lead removal may be considered to permit the implantation of an MRI conditional CIED system 0 0 0
Total number of patients with class IIB indications in three centers in 2009 128
Table II. Number of patients with class IIB indications for lead removal in class IIB in three centers in 2009
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2003-2009. The main reason for LE in class IIB was
lead damage.
Most frequently, the leads were extracted due
to different forms of damage; this group contains
patients with a damaged ICD lead (Sprint-Fidelis
predominantly), damaged PM leads in relatively
young patients with long-term life expectancy, and
Number of patients with class IIB indication Center A Center B Center C
Functional lead
Lead removal may be considered in patients with an abandoned functional lead that poses 5 0 8
a risk of interference with the operation of the active CIED system
Lead removal may be considered in patients with leads that are functional but 8 0 0
not being used. (i.e., RV pacing lead after upgrade to ICD)
Lead removal may be considered in patients who require specific imaging techniques 0 0 0
(e.g., MRI) that cannot be imaged due to the presence of the CIED system for which there 
is no other available imaging alternative for the diagnosis
Nonfunctional leads
Lead removal may be considered at the time of an indicated CIED procedure, in patients 71 15 21
with nonfunctional leads, if contraindications are absent Lead Lead Lead
fracture fracture fracture
– 47 (56%) – 12 (80%) – 12 (57%)
Lead removal may be considered to permit the implantation of an MRI conditional CIED system 0 0 0
Total number of patients with class IIB indications in three centers in 2009 128
Table II. Number of patients with class IIB indications for lead removal in class IIB in three centers in 2009
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patients with subclavian/anonymous vein occlu-
sion or stenosis and doubtful success of a further
lead implantation. The HRS criterion of too many
leads is fully acceptable for old patients with
midterm survival prognosis. A lot of procedures of
dramatic extractions of chronically implanted (10–
15–20 and more years ago) were performed. Such
LE procedures with old leads are very difficult. That
is why in the case of abandoned leads in patients
it would be much better to extract leads now than
in the future. Sometimes, only one superfluous
abandoned lead may cause unforeseeable problems
in the future, including vein occlusion, mutual lead
abrasions and interference, proximal ending lead
migration-related problems, and probably primary
(unrelated to pocket infection) lead-dependent en-
docarditis, which is more frequent in patients with
multiple leads. Every year, abandoned lead extrac-
tions are becoming more difficult and more risky.
The authors’ clinical experience with lead extrac-
tion is much older than the common computerized
database and inclined them to believe in the gen-
eral rule: “to leave behind as few abandoned leads
as possible”. This was especially so in young/middle-
aged patients because after a few years, in case of
trouble the authors would receive this patient once
again, but with more strongly ingrown leads.
In all three centers, the minimum annual number
of extractions recommended in the published expert
consensus (i.e., 20 leads annually) was achieved [1].
Erven’s et al. [6] study showed that in 40% of cen-
ters, lead extraction was performed annually in
fewer than 10 patients. In the Polish Registry, even in
the new center C, which started procedures in 2009,
lead extraction was performed in 46 patients. Such
practice might lead to a high success rate for proce-
dures with low risk of unnecessary complications.
The patients had the possibility to be referred to
a high volume extraction center, nationally identified
with the highest operator skills. It was confirmed in
other studies that the risks of a device-assisted lead
extraction decrease with the experience of the phy-
sician performing the procedure [4, 7–9].
The recently published consensus of Heart Rhythm
Society members found that just 18% of physicians
perform more than 50 extractions a year. The Heart
Rhythm Society’s recent expert consensus panel
also emphasized that the steepest decline in lead
extraction complication rates occurs during the ope-
rator’s first 30 cases and that the decline continues
up to 400 cases [1].
In Poland, cardiologists are the only operators and
procedures in the two main centers are performed in
the EP cath lab room. In the published study [6], in
some centers, a cardiothoracic surgeon is present
during procedures, and in a European survey [6] the
surgeon was the main operator in 34% of cases.
Henrikson’s et al. published data on behalf of the
HRS expert consensus revealed that 25% of extrac-
tion procedures are done without a surgeon or an
operating room on standby [10].
In Poland, the main tool for lead extraction is the
mechanical tool represented by Byrd dilators (Cook).
In none of the centers was the most modern way
of LE, with a laser extraction device, performed. Byrd
[11] reported the first excimer laser-assisted pace-
maker lead extraction in 1996. The multicenter ran-
domized pacing lead extraction with the excimer
sheath (PLEXES) trial found that laser-assisted
extraction was more efficacious than non-laser
techniques in 301 patients with no statistically sig-
nificant difference in life-threatening complications
between the laser and the non-laser groups [12].
However, a subsequent nonrandomized European
multicenter study of excimer laser-assisted pace-
maker and ICD lead extractions in 292 patients report-
ed a 5.1% complication rate [13]. 
Byrd [14] and Schaerf et al. [15] have reported
their experiences with the mechanical dilator
sheath that included 182 pacemaker and ICD leads
that were removed by them without any fatality.
Also in the experiences of the authors of the pres-
ent study, laser is not obligatory for effective and
non-complicated LE procedures [3, 16].
According to the literature, a polypropylene or
Teflon dilator sheath approach is safe and effective.
In most centers, only leads associated with sys-
temic infection were indicated for extraction before
the 1990s [2]. During this time period, most leads
extracted were removed surgically. Manual traction
or a simple device traction method was often found
to be unsuccessful and might lead to complications.
Before the current 2009 HRS consensus, the North
American Society Pacing and Electrophysiology
(NASPE) policy statement was published in 2000
[17], in which pacemaker or ICD-related sepsis or
endocarditis is a class 1 indication for lead extrac-
tion and localized pacemaker or ICD-related infec-
Variables Years
2003–2005 2006 2007 2008 2009
Number of LE 56 40 82 150 297
Number of implantations (ICD&PM)/million/year 479 571 681 769 871
LE/million/year 1.4 1.0 2.0 3.8 7.4
Expected LE/million/year (1.5–6.0% of implantations) 7.2–28.7 8.6–34.3 10.2–40.9 11.5–46.1 13.1–52.3
Table III. Number of lead extractions and expected lead extractions per million for 1 year
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tions are considered as class 2 indications for lead
extraction. In Bracke’s et al. study [18], no other indi-
cation for lead removal was assessed. According to
Kennergren et al. [2], the main indication for LE was
infection – only in 59% of patients. These data are
similar to the Polish Registry (in 47% of patients
infection was the indication for LE). Also in the Euro-
pean Survey published in Europace [6], infection is
the most frequent indication. Other papers on lead
extraction show the same percentage of this indica-
tion [4, 19, 20]. However, in the study by Calvagna
et al. and Bongiorni et al., infection was an indica-
tion for lead extraction in a higher number of pa-
tients [21, 22].
Subsequently, transvenous lead extraction me-
thods were developed. At the beginning of this cen-
tury, telescoping mechanical sheaths and locking
stylets as well as laser-assisted lead extraction were
widely introduced in clinical practice. Other factors
responsible for the increasing number of lead ex-
tractions were the increasing number of devices in
patients, better life expectancy, new indications, new
types of devices, as well as device and lead recalls
despite improved lead performance. These new facts
led to the increase in non-class 1 indications.
In Kennegren’s et al. study [2], class 2 was an in-
dication for lead extraction in 32% of patients. In
both Kennegren’s et al. study and the Polish reg-
istry, an increasing number of class 2 indications
were noted. In Bracke’s study [23], the complication
rate from extraction was considered before the pro-
cedure. Also in patients with venous occlusion and
in asymptomatic patients the decision about lead
removal should be first properly explored and dis-
cussed with the patient because of the risk of po-
tential complications.
In Wollmann’s et al. study [24], which compared
implantation of new, additional ICD leads and
extraction of defective leads and implantation, no
higher incidence of complications was found –
especially concerning oversensing or inappropriate
shocks – in the non-extraction group.
The registry, similar to the experience of the Swe-
dish center, shows that in the next few years more
class 2 lead removal indications can be expected [2].
On the other hand, the complication rate will decrease
mainly because of better lead removal tools and
higher volume center experience. All these factors
will help in extraction of leads, especially superflu-
ous ones.
In class 2a, in patients with ipsilateral venous occlu-
sion, which prevents access to the venous circulation,
an additional lead along with the old LE is reasonable. 
It should be mentioned that using the contrala -
te ral side in patients with one-side occlusion might
lead to dangerous both-side venous thrombosis.
Numerous reports of venous complications such as
stenosis, occlusions, and superior vena cava syndrome
have been published. Some studies have sugges -
ted risk factors for vein stenosis: infection, presence
of a temporary wire before implantation. Others
show that despite 40 years of experience with tran-
s cutaneous implanted intravenous pacing systems
and dozens of studies, it was not possible to iden-
tify clear risk factors (confirmed by independent stu -
dies) for venous stenosis or occlusion. 
A few factors were proposed as predictors of
severe venous stenosis/occlusion: presence of mul-
tiple pacemaker leads (compared to a single lead),
use of hormone therapy, personal history of venous
thrombosis, the presence of a temporary wire be -
fore implantation, previous presence of a pacemaker
(ICD as an upgrade), and the use of dual-coil leads.
That is why a decision during new lead implanta-
tion about “NOT removing the old lead” should
always be made by an experienced electrophysiol-
o gist or an invasive cardiologist. In the majority of
stu dies, venous obstruction in patients with PM or
ICD leads was found in up to 30% of cases [25, 26].
Also in nonfunctional lead, its removal may be
considered at the time of an indicated new proce-
dure (PM or ICD implantation/reimplantation), if
contraindications are absent. 
At this moment, class 2b with nonfunctional
leads compromises more patients. In the registry,
more than 30% of LE were just in class 2.
Extraction of nonfunctional leads – at present in
class 2b – is not mandatory and careful evaluation
has to precede the decision. However, in some
patients in class 2b, lead extraction should be con-
sidered, especially in young patients with long-term
life expectancy in whom superfluous lead removal
after 10 or 20 years might be much more difficult and
dangerous when compared to earlier approaches.
Late removal of such leads is strenuous, with long X
ray exposure and a long procedure time [28]. In the
same class 2b of lead extraction, potential risk of
venous occlusion, endocarditis due to lead isolation
abrasion, and other and abandoned leads should
be carefully estimated before operation.
For many cardiologists, the abandoned lead is
always the nucleus for vascular obstruction or infec-
tion [27]. An abandoned lead causes increased risk
of arrhythmia and in ICD patients may lead to inap-
propriate shocks. 
These 2b indications should not allow the ex -
perts to take a quick decision about implantation
of a new lead without old lead extraction. Also in
nonfunctional leads, the decision about LE should
be much more justified compared to functional
leads, because these leads will no longer be used,
which increases the risk of complications.
This study shows how many procedures are per-
formed due to class 2b indications (nonfunctional
leads).
Guidelines, although current, are not followed in
clinical practice and always a decision in class 2b
should be considered very carefully.
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tions are considered as class 2 indications for lead
extraction. In Bracke’s et al. study [18], no other indi-
cation for lead removal was assessed. According to
Kennergren et al. [2], the main indication for LE was
infection – only in 59% of patients. These data are
similar to the Polish Registry (in 47% of patients
infection was the indication for LE). Also in the Euro-
pean Survey published in Europace [6], infection is
the most frequent indication. Other papers on lead
extraction show the same percentage of this indica-
tion [4, 19, 20]. However, in the study by Calvagna
et al. and Bongiorni et al., infection was an indica-
tion for lead extraction in a higher number of pa-
tients [21, 22].
Subsequently, transvenous lead extraction me-
thods were developed. At the beginning of this cen-
tury, telescoping mechanical sheaths and locking
stylets as well as laser-assisted lead extraction were
widely introduced in clinical practice. Other factors
responsible for the increasing number of lead ex-
tractions were the increasing number of devices in
patients, better life expectancy, new indications, new
types of devices, as well as device and lead recalls
despite improved lead performance. These new facts
led to the increase in non-class 1 indications.
In Kennegren’s et al. study [2], class 2 was an in-
dication for lead extraction in 32% of patients. In
both Kennegren’s et al. study and the Polish reg-
istry, an increasing number of class 2 indications
were noted. In Bracke’s study [23], the complication
rate from extraction was considered before the pro-
cedure. Also in patients with venous occlusion and
in asymptomatic patients the decision about lead
removal should be first properly explored and dis-
cussed with the patient because of the risk of po-
tential complications.
In Wollmann’s et al. study [24], which compared
implantation of new, additional ICD leads and
extraction of defective leads and implantation, no
higher incidence of complications was found –
especially concerning oversensing or inappropriate
shocks – in the non-extraction group.
The registry, similar to the experience of the Swe-
dish center, shows that in the next few years more
class 2 lead removal indications can be expected [2].
On the other hand, the complication rate will decrease
mainly because of better lead removal tools and
higher volume center experience. All these factors
will help in extraction of leads, especially superflu-
ous ones.
In class 2a, in patients with ipsilateral venous occlu-
sion, which prevents access to the venous circulation,
an additional lead along with the old LE is reasonable. 
It should be mentioned that using the contrala -
te ral side in patients with one-side occlusion might
lead to dangerous both-side venous thrombosis.
Numerous reports of venous complications such as
stenosis, occlusions, and superior vena cava syndrome
have been published. Some studies have sugges -
ted risk factors for vein stenosis: infection, presence
of a temporary wire before implantation. Others
show that despite 40 years of experience with tran-
s cutaneous implanted intravenous pacing systems
and dozens of studies, it was not possible to iden-
tify clear risk factors (confirmed by independent stu -
dies) for venous stenosis or occlusion. 
A few factors were proposed as predictors of
severe venous stenosis/occlusion: presence of mul-
tiple pacemaker leads (compared to a single lead),
use of hormone therapy, personal history of venous
thrombosis, the presence of a temporary wire be -
fore implantation, previous presence of a pacemaker
(ICD as an upgrade), and the use of dual-coil leads.
That is why a decision during new lead implanta-
tion about “NOT removing the old lead” should
always be made by an experienced electrophysiol-
o gist or an invasive cardiologist. In the majority of
stu dies, venous obstruction in patients with PM or
ICD leads was found in up to 30% of cases [25, 26].
Also in nonfunctional lead, its removal may be
considered at the time of an indicated new proce-
dure (PM or ICD implantation/reimplantation), if
contraindications are absent. 
At this moment, class 2b with nonfunctional
leads compromises more patients. In the registry,
more than 30% of LE were just in class 2.
Extraction of nonfunctional leads – at present in
class 2b – is not mandatory and careful evaluation
has to precede the decision. However, in some
patients in class 2b, lead extraction should be con-
sidered, especially in young patients with long-term
life expectancy in whom superfluous lead removal
after 10 or 20 years might be much more difficult and
dangerous when compared to earlier approaches.
Late removal of such leads is strenuous, with long X
ray exposure and a long procedure time [28]. In the
same class 2b of lead extraction, potential risk of
venous occlusion, endocarditis due to lead isolation
abrasion, and other and abandoned leads should
be carefully estimated before operation.
For many cardiologists, the abandoned lead is
always the nucleus for vascular obstruction or infec-
tion [27]. An abandoned lead causes increased risk
of arrhythmia and in ICD patients may lead to inap-
propriate shocks. 
These 2b indications should not allow the ex -
perts to take a quick decision about implantation
of a new lead without old lead extraction. Also in
nonfunctional leads, the decision about LE should
be much more justified compared to functional
leads, because these leads will no longer be used,
which increases the risk of complications.
This study shows how many procedures are per-
formed due to class 2b indications (nonfunctional
leads).
Guidelines, although current, are not followed in
clinical practice and always a decision in class 2b
should be considered very carefully.
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In conclusion, the Polish Registry, 2003-2009,
shows an increasing number of lead extractions
with high volume centers having acceptable num-
bers of LE performed annually by physicians. The
main indication for LE is infection: systemic and
pocket. Increasingly in class 2, especially 2b, LE indi-
cation in every center during the study period was
found. 
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